Buccal Drug Delivery Systems Market Growth Forecast Through 2032

Buccal drug delivery systems are transitioning into a strategically vital delivery channel, driven by lifecycle-extension strategies and therapeutic shifts toward convenient, self-administered formats. Global revenues are projected to grow from 4.96 billion, supported by an expected 6.4% annual expansion across the forecast horizon.